FILTER
LATEST INTERVIEWS
Paul Murphy
MANAGER SOUTH AMERICA, MINING PLUS
Mining Plus, which provides technical services around the world, is growing its South American presence.
Dominique Doucet
FOUNDER & CEO, SIRIOS RESOURCES
Pioneers in the discovery of world-class gold deposits in the James Bay region, Sirios has discovered numerous showings in Nord-du-Québec and Eastern Canada.
Maname Fall
MANAGER & ASSOCIATE, SOJUFISC
SOJUFISC is a Senegalese law firm focused on supporting business in natural resources.
Bill Xue
PRESIDENT & CEO, WESTERN RESOURCES
TSX-listed Western Resources’ wholly owned subsidiary Western Potash Corp is fo-cused on developing the Milestone potash project in Saskatchewan.
Glenn J. Mullan
P.Geo ICD.D. CHAIRMAN OF THE BOARD, President & CEO, GOLDEN VALLEY MINES
Golden Valley Mines is based in Quebec and focused on early exploration and grassroots project generation in Canada and beyond.
Mark Ridley-Thomas
SUPERVISOR, LOS ANGELES COUNTY BOARD OF SUPERVISORS
The Board of Supervisors is the governing body of the County of Los Angeles, a charter county with a population of 10 million people and a budget of $33 billion. The Board has the unique function of serving as the executive and legislative head of the largest and most complex county government in the entire United States.
Justin Schroeder
SENIOR EXECUTIVE DIRECTOR – GLOBAL MARKETING & DESIGN, PCI PHARMA SERVICES
PCI Pharma Services provides integrated pharmaceutical development services to the global healthcare market.
Jonatan Julien
MINISTER OF ENERGY AND NATURAL RESOURCES, GOVERNMENT OF QUEBEC
Québec’s Minister of Energy and Natural Resources outlines his strategy to strengthen the region’s competitive advantages as a mining jurisdiction.
Abdourahmane Diop
CEO, LABOSOL- AGTS
LABOSOL- AGTS is a Senegalese law firm focused on business in the geotechnical engineering space.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
